Sakti Muhammad, Yurianto Henry, Kennedy Dave
Hasanuddin University, Makassar, South Sulawesi, Indonesia.
Department of Orthopaedics and Traumatology, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
Orthop J Sports Med. 2025 Mar 25;13(3):23259671251324472. doi: 10.1177/23259671251324472. eCollection 2025 Mar.
The medial collateral ligament (MCL) is one of the most commonly injured ligaments in the knee, accounting for 40% of all knee injuries. Autologous platelet concentrate, such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), has been proposed as a novel therapy in ligament injury.
To evaluate the effectiveness of PRP and PRF in recovery after MCL injury.
Controlled laboratory study.
This study was a randomized, single-blind, in vivo study on MCL injury in Wistar rats (). Rats that were sick, had a decrease in body weight of >10% after adaptation in the laboratory, or died were excluded. A total of 30 male Wistar rats were divided into 3 groups: group 1 (n=10) received no intervention, group 2 (n=7) received PRP, and group 3 (n=10) received PRF. The variables that were investigated included tensile strength and histopathological appearance. All statistical analysis was performed using SPSS 22.0 using the appropriate test based on the variable.
This study found that there was a significant difference in tensile strength across all groups ( = .004), with a significantly higher value in the PRF group compared with the PRP group (mean difference, 2.76; = .003). There was no significant correlation between tensile strength and ligament length ( = .34). Based on the histopathological data, this study found that PRF resulted in a higher amount of collagen cell orientation when compared with PRP and control ( = .049).
This study found that PRF was associated with greater tensile strength when compared with PRP and control. However, more studies with a longer observation period and further trials, especially in humans, should be conducted to confirm this finding.
PRF injection can be a novel therapy consideration for ligament injury, with a better result in both function and histological appearance when compared with PRP.
内侧副韧带(MCL)是膝关节最常受伤的韧带之一,占所有膝关节损伤的40%。自体血小板浓缩物,如富血小板血浆(PRP)和富血小板纤维蛋白(PRF),已被提议作为韧带损伤的一种新疗法。
评估PRP和PRF对MCL损伤后恢复的有效性。
对照实验室研究。
本研究是一项关于Wistar大鼠MCL损伤的随机、单盲体内研究()。排除患病、在实验室适应后体重下降>10%或死亡的大鼠。总共30只雄性Wistar大鼠分为3组:第1组(n = 10)不接受干预,第2组(n = 7)接受PRP,第3组(n = 10)接受PRF。研究的变量包括拉伸强度和组织病理学外观。所有统计分析均使用SPSS 22.0根据变量进行适当的检验。
本研究发现,所有组之间的拉伸强度存在显著差异(= .004),PRF组的值显著高于PRP组(平均差异,2.76;= .003)。拉伸强度与韧带长度之间无显著相关性(= .34)。根据组织病理学数据,本研究发现,与PRP和对照组相比,PRF导致更多的胶原细胞定向(= .049)。
本研究发现,与PRP和对照组相比,PRF与更大的拉伸强度相关。然而,应该进行更多观察期更长的研究和进一步试验,尤其是在人类中,以证实这一发现。
PRF注射可作为韧带损伤的一种新的治疗选择,与PRP相比,在功能和组织学外观方面均有更好的效果。